ArticleACS omega2026
Computational Insights into PB1-F2 Mediated Modulation of VDAC1: An Allosteric Mechanism in Mitochondrial Dysfunction.
Article in ACS omega, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The influenza-encoded virulence factor PB1-F2 has been implicated in a mitochondrial dysfunction of host immune cells through its interaction with the Voltage-Dependent Anion Channel 1 (VDAC1). This protein is a key outer mitochondrial membrane channel involved in ion and metabolite transport. Despite their well-known association, the precise interaction sites between these proteins remain unclear. In the current study, we employed multireplica all-atom molecular dynamics (MD), steered MD simulations, and docking approaches to investigate their mode of interaction. Our results reveal a putative binding site for PB1-F2 on the VDAC1 channel, as residue E73 has been reported to have physiological relevance in VDAC1 function; this region was initially explored as a potential interaction site. Furthermore, simulations based on multiple replicas revealed allosteric effects on VDAC1, increasing the dynamics of pore-lining residues and indicating a shift toward a probable closure-like conformation. We identify a stable binding interface at a global energy minimum, where PB1-F2 interacts via electrostatic interactions with the N-terminal pore-lining residues of VDAC1, which was also validated by voltage-driven simulations. We observed that due to the positive charge of PB1-F2, its interaction with the VDAC1 pore did not significantly affect the ionic conductance or selectivity of the channel. These findings provide molecular insights into how PB1-F2 modulates the function of VDAC1, reinforcing its role in modifying the permeability and possibly apoptosis induction. Understanding this interaction at an atomic level may inform novel strategies to deal with influenza-encoded virulence-induced dysfunctions of immune cells.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.